Among the nine genes in the prognostic model that we constructed, GABARAPL1 knockdown has been shown to inhibit the growth of prostate cancer cells in vitro or in vivo (Keulers et al., 2015). Here, GABARAPL1 is linked to Familial prostate cancer.